Feb 6 |
Ovid Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
|
Jan 18 |
Owning 31% shares,hedge funds owners seem interested in Ovid Therapeutics Inc. (NASDAQ:OVID),
|
Dec 1 |
Ovid Therapeutics to Present Five Abstracts Supporting its Epilepsy Programs at the 77th American Epilepsy Society Annual Meeting (2023)
|
Nov 9 |
Ovid Therapeutics (OVID) Upgraded to Buy: Here's Why
|
Nov 9 |
Q3 2023 Ligand Pharmaceuticals Inc Earnings Call
|
Nov 6 |
Ovid Therapeutics Inc (OVID) Reports Q3 2023 Financial Results
|
Nov 3 |
Ovid Therapeutics reports Q3 results
|
Nov 3 |
Ovid Therapeutics Reports Third Quarter 2023 Financial Results and Corporate Updates
|
Oct 29 |
We're Not Very Worried About Ovid Therapeutics' (NASDAQ:OVID) Cash Burn Rate
|